CPHI [CHINA PHARMA] DEF 14A: (Original Filing)
[]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac Granted Interim Injunctive Relief Regarding Filings Bearing a Falsified Company Seal and October 22, 2018 06:12 AM Eastern Daylight Time Lawful Directors Mr. Li Mr. Cao Hong Kong High Court Companies Registry Sinovac HK Sinovac Beijing BEIJING--(BUSINESS WIRE)--Senior management of Sinovac B]
SVA [SINOVAC BIOTECH] 6-K: Sinovac Granted Interim Injunctive Relief Regarding Filings Bearing
[Sinovac Granted Interim Injunctive Relief Regarding Filings Bearing a Falsified Company Seal and October 22, 2018 06:12 AM Eastern Daylight Time Lawful Directors Mr. Li Mr. Cao Hong Kong High Court Companies Registry Sinovac HK Sinovac Beijing BEIJING--(BUSINESS WIRE)--Senior management of Sinovac B]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[U.S. District Court in Massachusetts Denies 1Globe’s Motion for Preliminary Injunction to Enjoin Sinovac’s Issuance of Shares The Court found, among other things, that 1Globe failed to demonstrate that it has a reasonable likelihood of success on the merits of its direct and derivative federal secur]
SVA [SINOVAC BIOTECH] 6-K: U.S. District Court in Massachusetts Denies 1Globe’s Motion
[U.S. District Court in Massachusetts Denies 1Globe’s Motion for Preliminary Injunction to Enjoin Sinovac’s Issuance of Shares The Court found, among other things, that 1Globe failed to demonstrate that it has a reasonable likelihood of success on the merits of its direct and derivative federal secur]
SVA [SINOVAC BIOTECH] 6-K: October 15, 2018 08:02 PM Eastern Daylight Time
[October 15, 2018 08:02 PM Eastern Daylight Time BUSINESS WIRE BEIJING--( http://www.sinovacbio.com/?optionid=754&auto_id=874 As described in a previous press release The Board of Directors and management of publicly traded Sinovac Biotech Ltd., which remain unchanged by the actions of Sinobioway and]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[October 15, 2018 08:02 PM Eastern Daylight Time BUSINESS WIRE BEIJING--( http://www.sinovacbio.com/?optionid=754&auto_id=874 As described in a previous press release The Board of Directors and management of publicly traded Sinovac Biotech Ltd., which remain unchanged by the actions of Sinobioway and]
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[October 09, 2018 11:51 PM Eastern Daylight Time BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), became aware Monday October 8, 2018 that unauthorized changes have been made to the Hong Kong Companies Registry for Sinovac Biotech (Hong Kong) Limited (“Sinova]
SVA [SINOVAC BIOTECH] 6-K: October 09, 2018 11:51 PM Eastern Daylight Time
[October 09, 2018 11:51 PM Eastern Daylight Time BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ: SVA) ("Sinovac" or the "Company"), became aware Monday October 8, 2018 that unauthorized changes have been made to the Hong Kong Companies Registry for Sinovac Biotech (Hong Kong) Limited (“Sinova]
